Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
ID: ARPA-H-SOL-24-104Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
  1. 1
    Posted Mar 14, 2024, 8:58 PM UTC
  2. 2
    Updated Sep 25, 2024, 12:00 AM UTC
  3. 3
    Due Mar 4, 2029, 4:59 AM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.

Point(s) of Contact
Files
Title
Posted
Sep 25, 2024, 10:37 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has announced the Innovative Solutions Opening (ISO) under solicitation number ARPA-H-SOL-24-104, inviting proposals for groundbreaking healthcare technologies. This solicitation aims to support innovative, disease-agnostic research projects that can significantly enhance health outcomes. Key interest areas include breakthrough technologies for maternal and fetal health, genetic and cellular therapies, and novel diagnostic tools. Eligible participants include universities, non-profits, and small businesses, with a deadline for submission set until March 3, 2029. Proposers must initially submit a solution summary for feedback before proceeding with full proposals, which will be evaluated based on scientific merit, relevance to ARPA-H’s mission, and proposer capabilities. The solicitation emphasizes transformative, high-impact solutions over incremental research and excludes proposals for traditional policy changes or infrastructure projects. Awards will primarily include Other Transactions and Cooperative Agreements, allowing for flexibility in negotiation without the constraints of Federal Acquisition Regulation. The process encourages innovative approaches that incorporate open standards and interoperability in healthcare technology.
Sep 25, 2024, 10:37 PM UTC
The ARPA-H solicitation document outlines the requirements for submitting solution summaries in response to government Requests for Proposals (RFPs). It emphasizes the need for clarity and innovation in proposed technology concepts that address high-priority interest areas. Key sections include a Concept Summary where submitters detail their solutions and the problems they address, and Innovation and Impact, where the potential disruptiveness and superiority of the proposal over existing technologies should be demonstrated with measurable metrics. Additionally, the document specifies the Proposed Work section, where deliverables, milestones, and technical approaches must be clearly outlined alongside an analysis of technical challenges and risks. Team Organization and Capabilities highlight the roles of project members, supported by a Basis of Estimate (BOE) detailing financial requirements, work breakdown, and project costs. Submissions are restricted to six pages and must be formatted according to specified guidelines, ensuring readability and organization. This document serves to enhance the clarity and effectiveness of proposals within the context of federal funding opportunities, focusing on innovative solutions in healthcare and related fields.
Mar 28, 2024, 7:16 AM UTC
Sep 25, 2024, 10:37 PM UTC
Mar 28, 2024, 7:16 AM UTC
The ARPA-H Health Science Futures Office has released an Innovative Solutions Opening (ISO) solicitation aimed at advancing revolutionary healthcare technologies through proposals that tackle significant health challenges. Eligible applicants, including universities and small businesses, are encouraged to submit solution summaries by March 3, 2025, before full proposals can be considered, and multiple awards are anticipated with a focus on innovative, disruptive solutions in biomedical research. The initiative emphasizes novel technologies that can address a wide range of diseases and improve health outcomes, while excluding projects that represent merely incremental advances.
Lifecycle
Title
Type
Solicitation
Presolicitation
Similar Opportunities
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) under the Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID) program. This initiative aims to significantly enhance the speed and accuracy of diagnosing rare diseases, which affect approximately 30 million Americans, by developing innovative diagnostic support tools and a sustainable data platform optimized for AI-driven solutions. The RAPID program encompasses two phases over 4.5 years, focusing on extensive data curation, multimodal patient data collections, and the establishment of an AI-driven data commons, with the goal of reducing diagnostic delays and improving health management for underserved populations. Proposals are due by April 24, 2025, and interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at developing interventions to extend the healthspan of Americans by addressing age-related health decline. This initiative seeks to negotiate multiple Other Transaction Agreements (OTs) with eligible entities, focusing on three key technical areas: the development of an intrinsic capacity score, repurposing FDA-approved interventions, and creating second-generation interventions. The program is significant for transforming geriatric medicine into a preventive care model, emphasizing health equity and proactive health management for aging populations. Interested proposers can find further details and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with key deadlines for proposal submissions set for April and May 2025.
ARPA-H ImagiNg Data EXchange (INDEX)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the growing demand for imaging services amidst a shortage of qualified radiologists. This initiative is critical for improving healthcare outcomes by facilitating the development of AI-driven solutions through diverse and representative datasets, particularly focusing on cancer digital pathology, select radiology data, and surgical videos. Interested parties must submit their proposals by April 18, 2025, with inquiries directed to the INDEX Team at INDEX@arpa-h.gov.
ADAPT Contract Research Organization Support Services
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is seeking proposals for the ADAPT Contract Research Organization (CRO) Support Services aimed at enhancing precision cancer therapy. The primary objective is to develop an adaptive cancer treatment platform that integrates advanced analysis techniques and biomarker discovery to improve treatment strategies for metastatic cancer, focusing on therapy recommendations, evolutionary clinical trials, and a treatment analysis platform. This initiative is crucial for advancing cancer research and improving patient outcomes by matching therapies with evolving tumor biology in real-time. Proposals are due by April 11, 2025, with questions accepted until April 3, 2025. Interested parties can contact Steven Snyder at steven.snyder@arpa-h.gov or Clare Sanchez at clare.sanchez@arpa-h.gov for further information.
Ocular Laboratory for Analysis of Biomarkers (OCULAB)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program, aimed at advancing the diagnosis and treatment of ocular conditions, particularly dry eye disease (DED). The initiative seeks innovative solutions to develop a continuous monitoring biosensor integrated with therapeutic delivery systems, leveraging AI for non-invasive treatment methods. This program is significant for enhancing patient care and healthcare equity through advanced biomarker analysis and technology. Interested parties can contact the OCULAB Team at OCULAB@ARPA-H.gov for further information, with multiple awards anticipated as part of this funding opportunity, which is open until March 31, 2025.
BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003. The initiative aims to address high-risk biomedical challenges related to emerging infectious diseases and public health emergencies, with specific Areas of Interest (AOIs) including vaccine efficacy enhancement, portable viral diagnostics, and medical countermeasures for acute radiation syndrome. This opportunity is crucial for advancing public health preparedness and fostering innovation in medical technologies. Interested parties must have active registration with SAM.gov and are encouraged to submit abstracts by various deadlines, with the next significant closing date for AOI submissions set for March 15, 2024. For further inquiries, contact Sieaun Marks at DRIVeAcquisitions@hhs.gov.
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting proposals under the Broad Agency Announcement (BAA) BAA-23-100-SOL-00004 for advanced research and development of Medical Countermeasures (MCMs) aimed at addressing public health threats such as chemical, biological, radiological, and nuclear (CBRN) incidents, as well as emerging infectious diseases and pandemic influenza. The initiative seeks to foster public-private partnerships to enhance the development and responsiveness of life-saving MCMs, emphasizing the importance of technological maturity, regulatory compliance, and manufacturing standards in the evaluation process. This opportunity is critical for strengthening national health security and improving preparedness for future public health emergencies, with an open submission period running until September 25, 2028, at 4:30 PM Eastern Time. Interested parties can direct inquiries to BARDA-BAA@hhs.gov for further information.